Oral Cancer News | Tag Archive | head and neck cancer

Sharp rise in HPV-related oropharyngeal carcinoma — a legacy of the “sexual revolution”?

Thursday, April 1, 2010

Source: MedScape Today Author: Zosia Chustecka March 30, 2010 — The incidence of oropharyngeal carcinoma related to human papillomavirus (HPV) has been increasing in recent years, and there is speculation that this is the result of the “sexual revolution” of the 1960s. This increase in the incidence of HPV-related oropharyngeal cancer has important public health implications, British experts [...]

Fluoroscopically guided balloon dilation for pharyngoesophageal stricture after radiation therapy in patients with head and neck cancer

Tuesday, March 23, 2010

0 Comments

Source: AJR 2010; 194:1131-1136 Authors: Hong-Tao Hu et al. Objective: The purpose of this article is to assess the safety and long-term efficacy of fluoroscopically guided balloon dilation for pharyngoesophageal strictures after radiation therapy in patients with head and neck cancers. Materials and methods: From April 1997 to February 2009, fluoroscopically guided balloon dilation was performed in 17 [...]

George vs. The Dragon

Thursday, March 18, 2010

0 Comments

Source: ESPN.com Author: Rick Reilly DAY 17: Tuesday, March 9, 7:30 a.m. — Denver Nuggets coach George Karl pops in his mouthpiece and puts on his helmet and braces himself for a brutal 15 minutes, but this isn’t football. This is cancer radiation. We’re at Denver’s Swedish Medical Center. The helmet is actually a white, hard-mesh mask [...]

Introducing OraRisk HPV salivary diagnostic test by OralDNA Labs

Wednesday, March 3, 2010

0 Comments

Source: RDHmag Author: Staff NASHVILLE, Tennessee–OralDNA Labs , a leader in advancing wellness in dentistry through salivary diagnostics and a subsidiary of Quest Diagnostics, recently introduced a OraRisk HPV test. The test is a noninvasive, screening tool to identify the type(s) of oral human papillomavirus (also called HPV). Oral HPV is a mucosal viral infection that is a [...]

Roger Ebert: the essential man

Monday, February 22, 2010

0 Comments

Source: Esquire Magazine Author: Chris Jones It has been nearly four years since Roger Ebert lost his lower jaw and his ability to speak. Now television’s most famous movie critic is rarely seen and never heard, but his words have never stopped. For the 281st time in the last ten months Roger Ebert is sitting down to watch [...]

Serum prognostic markers in head and neck cancer

Wednesday, January 27, 2010

0 Comments

Source: Clincancerres François Meyer1, Élodie Samson1,2, Pierre Douville1, Thierry Duchesne2, Geoffrey Liu3 and Isabelle Bairati1 Authors’ Affiliations:1Laval University Cancer Research Center and 2Département de Mathématiques et Statistique, Laval University, Quebec, Quebec and 3Medical Biophysics Department, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada Corresponding Author:François Meyer, Cancer Research Center, Laval University, CHUQ, HDQ, 11, Cote Du Palais, Quebec, Quebec, G1R 2J6 Canada. Phone: 418-525-4444-15581; Fax: [...]

HPV, is it running rampant?

Friday, January 15, 2010

0 Comments

Source: WebMD Author: Bill Hendrick Jan. 14, 2010 — Cancer-causing human papillomavirus (HPV) spreads readily and quickly among partners in new sexual relationships, new research indicates. Scientists at McGill University, reporting in the journal Epidemiology, say they detected the virus in 64% of couples who reported engaging in vaginal sex for a median of 3.9 months. In 41% of 263 college [...]

Adding chemo helps head, neck cancer patients

Thursday, October 29, 2009

0 Comments

Source: HealthDayNews Author: Staff TUESDAY, Oct. 27 (HealthDay News) — Combining chemotherapy with radiation treatment for patients with advanced head and neck cancer increases their event-free survival to 2.2 years from just one year with radiotherapy alone, finds a new study. According to the study authors, “events” include cancer recurrence, new tumors or death. British researchers looked at the 10-year outcomes [...]

BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer

Wednesday, September 16, 2009

0 Comments

Source: PR Newswire Author: Staff WOBURN, Mass., Sept. 15 /PRNewswire/ — BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX (GM-CSF), for [...]

Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers

Wednesday, July 15, 2009

0 Comments

Source: Annals of Oncology, doi:10.1093/annonc/mdp268 Authors: A. S. Gokhale et al. Background: Patients treated with chemoradiotherapy (CRT) for head and neck cancers often require feeding tubes (FTs) due to toxicity. We sought to identify factors associated with a prolonged FT requirement. Patients and methods: We retrospectively reviewed 80 patients treated with CRT for head and neck cancers. The pharyngeal constrictors [...]

Tag Archive | "head and neck cancer"